Copyright
©The Author(s) 2020.
World J Stem Cells. Dec 26, 2020; 12(12): 1492-1510
Published online Dec 26, 2020. doi: 10.4252/wjsc.v12.i12.1492
Published online Dec 26, 2020. doi: 10.4252/wjsc.v12.i12.1492
Imaging | Imaging modality | Labelingmethod/agent | Cell type | Naïve/modified | Cell origin | Subject | Route of injection | Duration | Tumor | Outcome | Clinical translation | Ref. |
Optical | Fluorescent | FNPs | BM-MSCs | AlPcS4@FNPs@MSCs | Human | Mice | Intratumor | Immediately | Human osteosarcoma | Inhibition of tumor | Limited | Lenna et al[81] |
EGFP | BM-MSCs | TRAIL-MSCs | Mouse | Mice | Intravenous | 1-10 d | Mouse colon cancer | Inhibition of tumor | Limited | Zhang et al[82] | ||
VivoTrack 680 | BM-MSCs | MSCs | Human | Mice | Intravenous | 2-24 h | Breast cancer | Inhibition of tumor metastasis | Limited | Camorani et al[83] | ||
Bioluminescent | Rluc | UC-MSCs | HSV-ttk-MSCs | Human | Mice | Intratumor | 1-4 d | Breast cancer | Inhibition of tumor | Limited | Leng et al[84] | |
Fluc | BM-MSCs | MSC-Tet-TK/ MSC-TK | Mouse | Mice | Intratumor | 1 and 5 d | Mouse colon cancer | Inhibition of tumor | Limited | Kalimuthu et al[85] | ||
Fluc | BM-MSCs | MSC-CXCR4 | Mouse | Mice | Intravenous | 1 and 24 h | Breast cancer | Homing of genetically modified MSCs to tumor | Limited | Kalimuthu et al[86] | ||
Fluc | BM-MSCs | Naïve | Human | Mice | Intravenous | 5 to 8 wk | Breast cancer | Homing of MSCs to lung metastatic tumor | Limited | Meleshina et al[87] | ||
Fluc | BM-MSCs | Naïve | Human | Mice | Intravenous | 1 and 24 h | Thyroid and breast cancer | In vitro Dox delivery/homing of MSCs to tumor | Limited | Kalimuthu et al[88] | ||
Fluc | BM-MSCs | Naïve | Mouse | Mice | Intravenous | 1-11 d | Murine breast cancer | Homing and differentiation of MSCs to tumor | Limited | Wang et al[89] | ||
Fluc | BM-MSCs | MSCs-oncolytic adenovirus | Human | Mice | Intravenous | 15 min to 10 d | Murine large cell lung carcinoma | Homing of MSCs to tumor | Limited | Hakkarainen et al[90] | ||
Rluc | BM-MSCs | MSC-e23sFv-Fdt-tBid | Mouse | Mice | Intravenous | 24 h | Breast cancer and gastric cancer | Inhibition of tumor | Limited | Cai et al[91] | ||
Nuclear | PET | [18F]-FHBG | BM-MSCs | MSC-HSV1-TK | Human | Mice | Subcutaneous | 4 wk | Murine colon carcinoma | MSCs stably stay in tumor | Yes | Hung et al[60] |
124I | BM-MSCs | MSC-hNIS | Human | Mice | Intravenous | 72 h | Human hepatocellular carcinoma | Inhibition of tumor | Yes | Knoop et al[92] | ||
124I | BM-MSCs | MSC-hNIS | Mouse | Mice | Intravenous | 72 h | Mouse pancreatic tumor | Inhibition of tumor | Yes | Schug et al[93] | ||
γ-camera | 123I | BM-MSCs | MSC-hNIS | Human | Mice | Intravenous | 72 h | Human hepatocellular carcinoma | Inhibition of tumor | Yes | Knoop et al[92] | |
123I | BM-MSCs | HSP70B-NIS-MSC | Human | Mice | Intravenous | 0-72 h | Human hepatocellular carcinoma | Inhibition of tumor | Yes | Tutter et al[94] | ||
123I | BM-MSCs | MSC-hNIS | Mouse | Mice | Intravenous | 72 h | Mouse pancreatic tumor | Inhibition of tumor | Yes | Schug et al[93] | ||
123I | BM-MSCs | MSC-hNIS | Human | Mice | Intravenous | 72 h | Human hepatocellular carcinoma | Inhibition of tumor | Yes | Schug et al[95] | ||
99mTc | BM-MSCs | MSC-hNIS | Human | Mice | Intravenous | 3-14 d | Breast cancer | Inhibition of tumor | Yes | Dwyer et al[64] | ||
99mTc | BM-MSCs | MSC-hNIS | Human | Mice | Intravenous | 3-24 d | Human cervical cancer | Inhibition of tumor | Yes | Belmar-Lopez et al[96] | ||
MR | MRI | SPIO | BM-MSCs | MSC-hNIS | Human | Mice | Intravenous | 3-24 d | Human cervical cancer | Inhibition of tumor | Yes | Belmar-Lopez et al[96] |
SPIO@Au-NPs | BM-MSCs | MSC | Human | Mice | Intravenous | 0-72 h | Human glioma | Homing of MSC to tumor | Yes | Qiao et al[97] |
- Citation: Rajendran RL, Jogalekar MP, Gangadaran P, Ahn BC. Noninvasive in vivo cell tracking using molecular imaging: A useful tool for developing mesenchymal stem cell-based cancer treatment. World J Stem Cells 2020; 12(12): 1492-1510
- URL: https://www.wjgnet.com/1948-0210/full/v12/i12/1492.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v12.i12.1492